Faculty

Institution

Unit

Venue

Michelle M. Lebeau

Professor

University of Chicago

Affiliations

Medicine, Department of

Michelle M. Lebeau is currently serving as a Medicine, Department Of Professor at University of Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michelle M. Lebeau

University of Chicago

Professor

You can click a keyword to filter the displayed items

genetics hematology molecular biology oncology cancer genetics cytogenetics genomics gene expression cancer research medicine leukemia human genetics hematological malignancies cancer biology immunology chromosome biology tumor biology genome biology molecular genetics medical genetics oncogenes myeloid neoplasia medicinal research cancer genomics cancer cells molecular cancer acute myeloid leukemia chromosomal localization lymphoid neoplasia stem cell research cancer care chromosomal rearrangements myelodysplastic syndromes bone marrow transplantation genetic disorders cancer treatment disease progression malignant blood disorders tumor suppressors vascular biology protein science cellular therapy cancer discovery gene characterization therapy-related myeloid neoplasms cell transplantation gene function prognosis mutagenesis protein genetics pediatric hematology myelopoiesis gene regulation microrna detection chromosomal abnormalities structural molecular biology biological chemistry lymphocyte development human polymorphisms rna biology myeloid neoplasms molecular analysis myeloid leukemias myeloid leukemia blood cells yeast genomic medicine oncogenic agent molecular cloning malignant myeloid diseases myeloid disorders clinical mycology myeloid malignancies chromosomal translocations acute lymphoblastic leukemia long arm

Notable Scholarly Works

Notable Federal Grants

Collaborators

Approaches and Data Needed for Real-World Evaluation of Multicancer Early Detection Tests.. Journal of Clinical Oncology (2023)

Sean TunisMahesh K. B. ParmarHoward A. BurrisMichelle M. LeBeauLarry Kessler

cancer careradiation oncologyreal-world evaluationearly detectiononcologyclinical researchhealth sciences

Data From Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms. (2023)

Angela StoddartJianghong WangAnthony A. FernaldElizabeth M. DavisCamille R. JohnsonChunmei HuJason X. ChengMegan E. McNerneyMichelle M. Le Beau

medicinemarrow stromal cellspharmacologymyeloid neoplasiahematologycancer researchoncologycancer treatmentcytotoxic therapy-induced effects

Data From Dnmt3B7, a Truncated Dnmt3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis. (2023)

Mrinal Y. ShahAparna VasanthakumarNatalie Y. BarnesMaria E. FigueroaAnna KampChristopher HendrickKelly R. OstlerElizabeth M. DavisShang LinJohn AnastasiMichelle M. Le BeauIvan P. MoskowitzAri MelnickPeter PytelLucy A. Godley

immunologycarcinogenesisgene expressioncancer geneticsreporter gene assaycancer researchmolecular cancergeneticshuman tumorsoncologytumor heterogeneitydevelopmental biologycancer biologytumor biologylymphocyte development

Health Equity Challenges Facing Testing, Evaluation, and Implementation of Multi-Cancer Early Detection Tests.. Journal of Clinical Oncology (2023)

Michelle M. LeBeauLarry KesslerCarmen GuerraEsther KrofahKate Brain

public healthhealth equityoncologyclinical researchhealth scienceshealth policy

Supplementary Figure 1 From Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in I Nras- /I Driven Hematopoietic Transformation. (2023)

Jin XuKevin M. HaigisAri J. FirestoneMegan E. McNerneyQing LiElizabeth DavisShann-Ching ChenJoy NakitandweJames DowningTyler JacksMichelle M. Le BeauKevin Shannon

heme homeostasisdominant rolecell biologydisease progressiononcogene dosagehematologyhaematopoiesismolecular cancercancer genomicshematopoietic transformationtumor suppressorstumor biologygene expressionpharmacologyheme signalingtumor suppressor activitygeneticsoncologyoncogenesmedicinal research

The Modeling of Multicancer Early Detection (Mced) Tests’ Residual Risk and the Challenges of Mced Evaluation and Implementation. Cancer (2023)

Larry KesslerMichelle M. Le BeauRobert A. SmithFiona M. WalterRichard Wender

multicancer early detectionradiation oncologycancer researchmced evaluationoncologycancer biologyresidual risk

Author Correction: Genome-Wide Association Study Identifies Susceptibility Loci for Acute Myeloid Leukemia. Nature Communications (2022)

Wei-Yu LinSarah E. FordhamEric HungateNicola J. SunterClaire ElstobYaobo XuCatherine ParkAnne QuanteKonstantin StrauchChristian GiegerAndrew SkolThahira RahmanLara Sucheston-CampbellJunke WangTheresa HahnAlyssa I. Clay-GilmourGail L. JonesHelen J. MarrGraham H. JacksonTobias MenneMathew CollinAdam IveyRobert K. HillsAlan K. BurnettNigel H. RussellJude FitzgibbonRichard A. LarsonMichelle M. Le BeauWendy StockOlaf HeidenreichAbrar AlharbiDavid J. AllsupRichard S. HoulstonJean NordenAnne M. DickinsonElisabeth DouglasClare LendremAnn K. DalyLouise PalmKim PiechockiSally JeffriesMartin BornhäuserChristoph RölligHeidi AltmannLeo RuhnkeDesiree KunadtLisa WagenführHeather J. CordellRebecca DarlayMette K. AndersenMaria C. FontanaGiovanni MartinelliGiovanni MarconiMiguel A. SanzJosé CerveraInés Gómez-SeguíThomas CluzeauChimène MoreilhonSophie RaynaudHeinz SillMaria Teresa VosoFrancesco Lo-CocoHervé DombretMeyling CheokClaude PreudhommeRosemary E. GaleDavid LinchJulia Gaal-WesingerAndras MassziDaniel NowakWolf-Karsten HofmannAmanda GilkesKimmo PorkkaJelena D. Milosevic FeenstraRobert KralovicsDavid GrimwadeManja MeggendorferTorsten HaferlachSzilvia KrizsánCsaba BödörFriedrich StölzelKenan OnelJames M. Allan

genomicscancer geneticsgenome-wide association studieshematologygeneticsoncologyacute myeloid leukemiamedical geneticshuman geneticshealth sciencesauthor correction

Chromosomal Aberrations in Cancer. Holland‐Frei Cancer Medicine (2022)

Megan E. McNerneyAri J. RosenbergMichelle M. Le Beau

medicinecancer geneticscancer researchgeneticschromosome biologyoncologycancer biologycytogeneticschromosomal aberrations

Egr1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy. Experimental Hematology (2022)

Angela StoddartAnthony A. FernaldElizabeth M. DavisMegan E. McNerneyMichelle M. Le Beau

immunologytreatment and preventionmedicinecancer carestem cell researchhematologyregenerative medicinefitness advantagegeneticsfitnesstherapy resistanceoncologystem cellscancer treatmenthematopoietic stem cells

Inherited Cancer Predisposing Mutations in Patients With Therapy‐Related Myeloid Neoplasms. British Journal of Haematology (2022)

Andrew J. ShihTomi JunAndrew D. SkolRiyue BaoLei HuangSapana VoraMegan E. McNerneyEric A. HungateMichelle M. Le BeauRichard A. LarsonAaron ElliottHsiao‐Mei LuRobert HuetherFelicia HernandezFriedrich StölzelJames M. AllanKenan Onel

hematological malignanciesdermatologycancer geneticsmyeloid neoplasiahematologycancer researchgeneticscancer genomicsoncologytherapy-related myeloid neoplasmsinherited cancermutagenesis

1
2
3
4
5
47
10 / page

Michelle M. Lebeau

Professor

University of Chicago

Affiliations

Medicine, Department of

Michelle M. Lebeau is currently serving as a Medicine, Department Of Professor at University of Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michelle M. Lebeau

University of Chicago

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Approaches and Data Needed for Real-World Evaluation of Multicancer Early Detection Tests.. Journal of Clinical Oncology (2023)

Sean TunisMahesh K. B. ParmarHoward A. BurrisMichelle M. LeBeauLarry Kessler

cancer careradiation oncologyreal-world evaluationearly detectiononcologyclinical researchhealth sciences

Data From Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms. (2023)

Angela StoddartJianghong WangAnthony A. FernaldElizabeth M. DavisCamille R. JohnsonChunmei HuJason X. ChengMegan E. McNerneyMichelle M. Le Beau

medicinemarrow stromal cellspharmacologymyeloid neoplasiahematologycancer researchoncologycancer treatmentcytotoxic therapy-induced effects

Data From Dnmt3B7, a Truncated Dnmt3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis. (2023)

Health Equity Challenges Facing Testing, Evaluation, and Implementation of Multi-Cancer Early Detection Tests.. Journal of Clinical Oncology (2023)

Michelle M. LeBeauLarry KesslerCarmen GuerraEsther KrofahKate Brain

public healthhealth equityoncologyclinical researchhealth scienceshealth policy

Supplementary Figure 1 From Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in I Nras- /I Driven Hematopoietic Transformation. (2023)

Jin XuKevin M. HaigisAri J. FirestoneMegan E. McNerneyQing LiElizabeth DavisShann-Ching ChenJoy NakitandweJames DowningTyler JacksMichelle M. Le BeauKevin Shannon

The Modeling of Multicancer Early Detection (Mced) Tests’ Residual Risk and the Challenges of Mced Evaluation and Implementation. Cancer (2023)

Larry KesslerMichelle M. Le BeauRobert A. SmithFiona M. WalterRichard Wender

multicancer early detectionradiation oncologycancer researchmced evaluationoncologycancer biologyresidual risk

Author Correction: Genome-Wide Association Study Identifies Susceptibility Loci for Acute Myeloid Leukemia. Nature Communications (2022)

genomicscancer geneticsgenome-wide association studieshematologygeneticsoncologyacute myeloid leukemiamedical geneticshuman geneticshealth sciencesauthor correction

Chromosomal Aberrations in Cancer. Holland‐Frei Cancer Medicine (2022)

Megan E. McNerneyAri J. RosenbergMichelle M. Le Beau

medicinecancer geneticscancer researchgeneticschromosome biologyoncologycancer biologycytogeneticschromosomal aberrations

Egr1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy. Experimental Hematology (2022)

Angela StoddartAnthony A. FernaldElizabeth M. DavisMegan E. McNerneyMichelle M. Le Beau

Inherited Cancer Predisposing Mutations in Patients With Therapy‐Related Myeloid Neoplasms. British Journal of Haematology (2022)

hematological malignanciesdermatologycancer geneticsmyeloid neoplasiahematologycancer researchgeneticscancer genomicsoncologytherapy-related myeloid neoplasmsinherited cancermutagenesis

1
2
3
4
5
47
10 / page

Similar Faculty Members

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Garry Nolan

Institution

Stanford University

immunology

cell biology

Thomas Kipps

Institution

University of California, San Diego

pathology

hematological malignancies

Michael P. Snyder

Institution

Stanford University

genetics

molecular biology

Josef Prchal

Institution

University of Utah

polycythemia vera

haematopoiesis

Michael W. N. Deininger

Institution

University of Utah

molecular medicine

pathology

Andrew Godwin

Institution

University of Kansas

oncology

cancer research

Daniel G. Tenen

Institution

Harvard University

molecular diagnostics

molecular medicine

Wendy Stock

Institution

University of Chicago

acute leukemia

pediatric hematology

Stephen D. Nimer

Institution

University of Miami

molecular biology

haematopoiesis

Similar Faculty Members

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Garry Nolan

Institution

Stanford University

immunology

cell biology

Thomas Kipps

Institution

University of California, San Diego

pathology

hematological malignancies

Michael P. Snyder

Institution

Stanford University

genetics

molecular biology

Josef Prchal

Institution

University of Utah

polycythemia vera

haematopoiesis

Michael W. N. Deininger

Institution

University of Utah

molecular medicine

pathology

Andrew Godwin

Institution

University of Kansas

oncology

cancer research

Daniel G. Tenen

Institution

Harvard University

molecular diagnostics

molecular medicine

Wendy Stock

Institution

University of Chicago

acute leukemia

pediatric hematology

Stephen D. Nimer

Institution

University of Miami

molecular biology

haematopoiesis